Synta66
SIGMA/SML1949 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 835904-51-3
Empirical Formula (Hill Notation): C20H17FN2O3
Molecular Weight: 352.36
Linear Formula: C20H17FN2O3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI key | GFEIWXNLDKUWIK-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O=C(NC1=CC=C(C2=C(OC)C=CC |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | 2-8°C |
| Application: | Synta66 has been used: • as a Ca2+ release-activated calcium (CRAC) channel inhibitor to study its effects on ORAI isoforms • as an ORAI1 blocker to study its effects on the entry of Ca2+ in chronic lymphocytic leukemia (CLL) B cells • as a CRAC blocker to study its effects on the influx of Ca2+ by store-operated Ca2+ entry (SOCE) in enamel cells |
| Biochem/physiol Actions: | A selective SOCE inhibitor that blocks CRAC current (ICRAC) without significant off-target potency or affinity. |
| Biochem/physiol Actions: | Synta66 (S66) is a CRAC (Ca2+ release-activated Ca2+) channel inhibitor that blocks SOCE (store-operated Ca2+ entry) upon Ca2+ depletion from intracellular stores by thapsigargin in human vascular smooth muscle cells (VSMCs) with high potency (IC50 = 26 nM & 43 nM based on maximum Ca2+ level & rate of increase, respectly). Synta66 exhibits no affinity toward a range of receptors and ion channels (e.g. L-type Ca2+ channel) and does not affect TRPC1/5-mediated SOCE or store-operated non-selective cationic current. Leukocytes are reported to be less sensitive to CRAC inhibition by Synta66 (IC50 = 1.76 μM/HL-60, 1 ?M/Jurkat, 1.4 μM/rat RBL). |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

